| 标题 |
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Peter M. Voorhees; Douglas W. Sborov; Jacob P. Laubach; Jonathan L. Kaufman; Brandi Reeves; et al 出版日期:2023-09-11 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)